Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 27, 2018

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has sixty-four approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms

US Patents:	0
Tradenames:	51
Ingredients:	50
NDAs:	64

Drugs and US Patents for Glenmark Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Inc	LITHIUM CARBONATE	lithium carbonate	TABLET, EXTENDED RELEASE;ORAL	091544-001	Dec 27, 2010	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	FROVATRIPTAN SUCCINATE	frovatriptan succinate	TABLET;ORAL	204730-001	Mar 11, 2016	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	ATOMOXETINE HYDROCHLORIDE	atomoxetine hydrochloride	CAPSULE;ORAL	079019-003	May 30, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	TELMISARTAN	telmisartan	TABLET;ORAL	090032-001	Jul 7, 2014	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington

AstraZeneca

McKinsey

Argus Health

Deloitte

QuintilesIMS

Cipla

Moodys

Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.